The adult 21-valent pneumococcal conjugate vaccine (V116) shows strong immune responses and tolerability in vaccine-naive at risk adults.

A recent clinical trial found that a new TROP2-targeted antibody-drug conjugate (ADC) showed encouraging efficacy in treating ...

The partnership will focus on Crescent’s PD-1/VEGF inhibitor CR-001 and Kelun-Biotech’s SKB105, both of which the companies ...

Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugate Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and ...

To adapt to changing environmental pressures, bacteria have developed various methods that allow them to uptake exogenous DNA and incorporate it into their own genomes. One of these processes is ...

This is Your Quick Training Tip, a chance to learn how to work smarter in just a few moments so you can get right to your workout. Building strength is a science, and few gyms that science better than ...